NCT03436992View on ClinicalTrials.gov

Estrogen and Diabetes

NACompletedINTERVENTIONAL

Enrollment

143

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

September 1, 2023

Study Completion Date

December 31, 2023

Conditions

Diabetes Mellitus, Type 1

Interventions

DIETARY_SUPPLEMENT

Antioxidant Cocktail

Vitamin C, Vitamin E, alpha lipoic acid

DIETARY_SUPPLEMENT

Resveratrol

1500 mg trans-resveratrol

OTHER

Placebo

placebo

Trial Locations (2)

30912

Augusta University, Augusta

Georgia Prevention Institute, Augusta

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Augusta University

OTHER

NCT03436992 - Estrogen and Diabetes | Biotech Hunter | Biotech Hunter